How many stocks are there of Ibio?
The current number of stocks of Ibio is 610,000 undefined.
Ibio Stocks 2024
Ibio Stocks
610,000
Ticker
IBIO
ISIN
US4510332038
WKN
A2JNBU
In 2024, Ibio had 610,000 outstanding stocks, a 0% change from the 610,000 stocks in the previous year.
The Ibio Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2030e | 610 |
| 2029e | 610 |
| 2028e | 610 |
| 2027e | 610 |
| 2026e | 610 |
| 2025e | 610 |
| 2024e | 610 |
| 2023 | 610 |
| 2022 | 440 |
| 2021 | 390 |
| 2020 | 130 |
| 2019 | 40 |
| 2018 | 20 |
| 2017 | 20 |
| 2016 | 20 |
| 2015 | 10 |
| 2014 | 10 |
| 2013 | 10 |
| 2012 | 10 |
| 2011 | 10 |
| 2010 | 10 |
| 2009 | - |
| 2008 | - |
| 2007 | - |
Ibio shares outstanding US4510332038 · A2JNBU
The number of shares was Ibio in 2023 — This indicates how many shares 610,000 is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Ibio earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Ibio's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Ibio’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Ibio's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2007 | 0 Aktien |
| 2008 | 0 Aktien |
| 2009 | 0 Aktien |
| 2010 | 10,000 Aktien |
| 2011 | 10,000 Aktien |
| 2012 | 10,000 Aktien |
| 2013 | 10,000 Aktien |
| 2014 | 10,000 Aktien |
| 2015 | 10,000 Aktien |
| 2016 | 20,000 Aktien |
| 2017 | 20,000 Aktien |
| 2018 | 20,000 Aktien |
| 2019 | 40,000 Aktien |
| 2020 | 130,000 Aktien |
| 2021 | 390,000 Aktien |
| 2022 | 440,000 Aktien |
| 2023 | 610,000 Aktien |
| 2024e | 610,000 Aktien |
| 2025e | 610,000 Aktien |
| 2026e | 610,000 Aktien |
| 2027e | 610,000 Aktien |
| 2028e | 610,000 Aktien |
| 2029e | 610,000 Aktien |
| 2030e | 610,000 Aktien |
Ibio Aktienanalyse
What does Ibio do?
Ibio Inc is a US biopharmaceutical company founded in 2008. It is headquartered in Bryan, Texas and employs approximately 130 employees. The company is listed on the New York Stock Exchange (NYSE: IBIO). The business model of Ibio Inc is to develop innovative biopharmaceutical products and sell them in the market. The company utilizes plant expression systems technology to extract proteins and antibodies from plant cells, which significantly reduces production costs, allowing for cost-efficient manufacturing of rare and expensive medications. The company is divided into various divisions, including research and development, manufacturing of biopharmaceuticals, and vaccine production. In the research and development field, Ibio Inc focuses on innovative products in oncology and infectious diseases. One example of their products is IBIO-100, which is intended for the treatment of breast and prostate cancer. Another product of Ibio Inc is IBIO-CFB03, a vaccine against COVID-19 produced using plant expression technology. In 2020, the company formed a partnership with the Brazilian biotech company CC-Pharming Ltda. for this vaccine. Additionally, Ibio Inc is involved in the production of biopharmaceuticals, including various antibodies used in the treatment of cancer. One example is IBIO-101, a monoclonal antibody against the tumor protein folate receptor alpha, which can be used in the therapy of ovarian, breast, and lung cancer. The company collaborates closely with various partners in the pharmaceutical industry to bring its products to the market. This includes working with CC-Pharming, with whom they developed the COVID-19 vaccine, as well as Chinese biotech company CC-Pharming Shanghai Co. Ltd., which serves as a production partner for Ibio Inc. Ibio Inc is an innovative company that enables cost-efficient production of biopharmaceuticals through the use of plant expression technology. The company primarily focuses on oncology and infectious diseases and collaborates with partners in the pharmaceutical industry to bring its products to the market. Ibio ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Ibio's Shares Outstanding
Ibio's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Ibio’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Ibio’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Ibio’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Ibio stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Ibio are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Ibio evolved in recent years?
The number of shares of Ibio has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Ibio as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Ibio?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Ibio pay?
Over the past 12 months, Ibio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ibio is expected to pay a dividend of 0 USD.
What is the dividend yield of Ibio?
The current dividend yield of Ibio is .
When does Ibio pay dividends?
Ibio pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Ibio?
Ibio paid dividends every year for the past 0 years.
What is the dividend of Ibio?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Ibio located?
Ibio is assigned to the 'Health' sector.
Wann musste ich die Aktien von Ibio kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Ibio from 9/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/20/2024.
When did Ibio pay the last dividend?
The last dividend was paid out on 9/20/2024.
What was the dividend of Ibio in the year 2023?
In the year 2023, Ibio distributed 0 USD as dividends.
In which currency does Ibio pay out the dividend?
The dividends of Ibio are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Ibio
Our stock analysis for Ibio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ibio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
